Resources Contact Us Home
Immunoreactive peptides from Epstein-Barr virus

Image Number 3 for United States Patent #7988972.

The Epstein-Barr virus (EBV) specific polypeptides ETFTETWNRFITHTE (SEQ. ID NO: 1), GMLEASEGLDGWIHQ (SEQ. ID NO:2), HQQGGWSTLIEDNIP (SEQ. ID NO:3), and KQKHPKKVKQAFNPL (SEQ. ID NO:4) are among those disclosed. Also disclosed are the use of these polypeptides for the production of polypeptide-specific antibodies and the diagnosis and treatment of EBV-associated disease.

  Recently Added Patents
Wireless updating of hearing devices
Semiconductor device and method for manufacturing same
Fabric care compositions comprising front-end stability agents
Method and system for billing based on color component histograms
Credit flow control scheme in a router with flexible link widths utilizing minimal storage
Inflatable workshop
Method for treating oncological diseases
  Randomly Featured Patents
Novel cobalt-base superalloy and cast and welded industrial gas turbine components thereof and method
Fuel pressure regulator
Bifocal multiorder diffractive lenses for vision correction
Peptoid mixtures
System gaming
High-pressure fuel pump with a ball valve in the low-pressure inlet
Internal combustion engine control
Sustained release formulations of insect repellent
Petunia plant named `Danlittun4`
Patient lifting pad